Rising Demand for Microbiome-Based Therapies to Propel Live Biotherapeutics Market Through 2034
The global live biotherapeutics market is entering a transformative decade, driven by accelerating microbiome research, regulatory advancements, and expanding clinical pipelines. Valued at US$ 105.5 Mn in 2023, the industry is projected to grow at a robust compound annual growth rate (CAGR) of 14% from 2024 to 2034, reaching more than US$ 422.9 Mn by the end of 2034. This strong growth...
0 Comments 0 Shares 108 Views 0 Reviews
Sponsored